Abnormal Cerebrovascular Activity, Perfusion, and Glymphatic Clearance in Lewy Body Diseases
- PMID: 38817039
- PMCID: PMC11341260
- DOI: 10.1002/mds.29867
Abnormal Cerebrovascular Activity, Perfusion, and Glymphatic Clearance in Lewy Body Diseases
Abstract
Cerebrovascular activity is not only crucial to optimal cerebral perfusion, but also plays an important role in the glymphatic clearance of interstitial waste, including α-synuclein. This highlights a need to evaluate how cerebrovascular activity is altered in Lewy body diseases. This review begins by discussing how vascular risk factors and cardiovascular autonomic dysfunction may serve as upstream or direct influences on cerebrovascular activity. We then discuss how patients with Lewy body disease exhibit reduced and delayed cerebrovascular activity, hypoperfusion, and reductions in measures used to capture cerebrospinal fluid flow, suggestive of a reduced capacity for glymphatic clearance. Given the lack of an existing framework, we propose a model by which these processes may foster α-synuclein aggregation and neuroinflammation. Importantly, this review highlights several avenues for future research that may lead to treatments early in the disease course, prior to neurodegeneration. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Keywords: Parkinson's disease; cerebrovascular activity; dementia with Lewy bodies; glymphatic system; neurovascular complex.
© 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Figures
References
-
- Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. Journal of neuropathology and experimental neurology. 1961;20(2):237–44. - PubMed
-
- Kosaka K, Oyanagi S, Matsushita M, Hori A. Presenile dementia with Alzheimer-, Pick-and Lewy-body changes. Acta neuropathologica. 1976;36(3):221–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UF1 NS100598/NS/NINDS NIH HHS/United States
- P30 GM122734/GM/NIGMS NIH HHS/United States
- R61 MH125126/MH/NIMH NIH HHS/United States
- R03 AG075408/AG/NIA NIH HHS/United States
- P20AG068077/AG/NIA NIH HHS/United States
- R01 AG062624/AG/NIA NIH HHS/United States
- R01NS133569/NS/NINDS NIH HHS/United States
- RF1 AG083744/AG/NIA NIH HHS/United States
- P30 AG086404/AG/NIA NIH HHS/United States
- R03AG075408/AG/NIA NIH HHS/United States
- R01 NS098494/NS/NINDS NIH HHS/United States
- P20 AG068077/AG/NIA NIH HHS/United States
- R01 NS129407/NS/NINDS NIH HHS/United States
- R01 NS133569/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
